…
Capstone Holding Corp. engages in the distribution of masonry stone products in the Midwest and Northeast United States. The company offers masonry stone products, such as manufactured and natural stone cladding products, natural stone landscape products, and related goods for residential and commercial construction. The company was formerly known as Capstone Therapeutics Corp. and changed its name to Capstone Holding Corp. in February 2022. Capstone Holding Corp. was incorporated in 1987 and is based in Alsip, Illinois.
Source: TradingView
The charts and visual representations are sourced from TradingView through embedded widgets. For any issues with chart display, please visit the TradingView website
A unique technical analysis driven score developed by Kalkine showing momentum in stock prices based on select technical indicators identified.
Public information on Capstone Holding Corp (NASDAQ: CAPS) is limited and the company appears to be a publicly listed special purpose acquisition company that has not disclosed an operating business or a completed business combination. Its long-term prospects therefore depend on successfully identifying and closing an acquisition and on the operating performance of any acquired target; investors may find exposure to an acquisition pipeline and potential post‑combination upside of interest.
Material investment risks include failure to complete a qualifying business combination within the SPAC’s timeframe, dilution and sponsor conflicts, the absence of operating history, and post‑deal market and regulatory volatility.
Note: The summary and risk score provided above is created by AI and should not be construed as a recommendation of Kalkine.
| Breakdown | 2025-12-31 | 2024-12-31 | 2023-12-31 | 2022-12-31 | 2021-12-31 |
|---|---|---|---|---|---|
| Type | yearly | yearly | yearly | yearly | yearly |
| Date | 2025-12-31 | 2024-12-31 | 2023-12-31 | 2022-12-31 | 2021-12-31 |
| Income before tax | -14.05M | -3.00M | -3.58M | 3.10M | 4.36M |
| Net income | -21.93M | -2.56M | -3.82M | 2.31M | 3.92M |
| Selling general administrative | 14.37M | 10.21M | 10.87M | 12.54M | 11.68M |
| Gross profit | 10.79M | 9.57M | 9.61M | 16.53M | 16.32M |
| Reconciled depreciation | 0.39M | 0.52M | 0.31M | 0.24M | 0.39M |
| Ebit | -11.38M | -0.64M | -2.06M | - | - |
| Ebitda | -10.99M | -0.12M | -1.75M | 4.23M | 5.80M |
| Depreciation and amortization | 0.39M | 0.52M | 0.31M | - | - |
| Operating income | -3.58M | -0.64M | -1.26M | 3.99M | 4.64M |
| Other operating expenses | 50.46M | 45.51M | 49.61M | - | - |
| Interest expense | 3.89M | 1.48M | 1.53M | 0.90M | 1.06M |
| Tax provision | 7.18M | 0.44M | 0.23M | 0.78M | 0.44M |
| Net interest income | -3.89M | -1.48M | -1.53M | -0.90M | -1.06M |
| Income tax expense | -7.18M | -0.44M | 0.23M | - | - |
| Total revenue | 46.88M | 44.88M | 48.35M | 61.56M | 66.74M |
| Total operating expenses | 14.37M | 10.21M | 10.87M | 57.57M | 62.11M |
| Cost of revenue | 36.09M | 35.31M | 38.74M | 45.03M | 50.43M |
| Total other income expense net | -10.47M | -2.37M | -2.33M | - | 0.78M |
| Net income from continuing ops | -21.23M | -2.56M | -3.82M | 2.31M | 3.92M |
| Breakdown | 2025-12-31 | 2024-12-31 | 2023-12-31 | 2022-12-31 | 2021-12-31 |
|---|---|---|---|---|---|
| Type | yearly | yearly | yearly | yearly | yearly |
| Date | 2025-12-31 | 2024-12-31 | 2023-12-31 | 2022-12-31 | 2021-12-31 |
| Total assets | 51.38M | 47.22M | 52.70M | 65.21M | 64.07M |
| Intangible assets | 1.84M | 0.05M | 0.01M | - | - |
| Other current assets | 0.35M | 0.56M | 0.70M | 0.52M | 0.32M |
| Total liab | 38.92M | 50.28M | 50.26M | 31.88M | 34.99M |
| Total stockholder equity | 12.45M | -3.06M | 2.44M | 33.33M | 29.08M |
| Other current liab | 2.29M | 0.39M | - | - | 0.04M |
| Common stock | 0.00M | - | - | - | - |
| Capital stock | 1.97M | 0.00M | 0.00M | 25.16M | 22.84M |
| Retained earnings | -218.04M | -196.10M | -190.61M | -184.87M | -184.86M |
| Good will | 18.46M | 23.29M | 23.29M | - | - |
| Cash | 0.73M | 0.01M | 0.05M | 0.02M | 0.05M |
| Total current liabilities | 22.92M | 12.55M | 14.96M | 11.89M | 12.39M |
| Net debt | 18.78M | 16.60M | 17.25M | 25.26M | 24.11M |
| Short term debt | 15.68M | 8.85M | - | - | - |
| Short long term debt | 14.02M | 8.11M | 11.18M | 8.37M | 5.71M |
| Short long term debt total | 19.51M | 16.61M | - | - | - |
| Other stockholder equity | 230.46M | 193.04M | - | - | - |
| Total current assets | 23.00M | 12.80M | 17.08M | 20.97M | 18.49M |
| Long term investments | - | - | 0.00M | 8.00M | 8.00M |
| Net receivables | 4.86M | 2.76M | 2.58M | 3.03M | 3.95M |
| Long term debt | 9.34M | 6.32M | 6.12M | 16.91M | 18.45M |
| Inventory | 17.06M | 9.47M | 12.84M | 17.40M | 14.16M |
| Accounts payable | 4.96M | 3.30M | - | - | - |
| Accumulated other comprehensive income | -0.00M | - | - | - | - |
| Non currrent assets other | -22.41M | 0.25M | 0.05M | 0.05M | 0.05M |
| Non current assets total | 5.37M | 34.42M | 35.62M | 44.24M | 45.58M |
| Capital lease obligations | 5.49M | 2.17M | 3.03M | 3.52M | 4.18M |
| Breakdown | 2025-12-31 | 2024-12-31 | 2023-12-31 | 2022-12-31 | 2021-12-31 |
|---|---|---|---|---|---|
| Type | yearly | yearly | yearly | yearly | yearly |
| Date | 2025-12-31 | 2024-12-31 | 2023-12-31 | 2022-12-31 | 2021-12-31 |
| Investments | - | -0.12M | -0.21M | -0.17M | -0.93M |
| Total cashflows from investing activities | -6.91M | -0.12M | -0.21M | - | - |
| Net borrowings | 9.42M | -3.53M | -1.01M | - | - |
| Total cash from financing activities | 12.12M | -3.74M | -1.21M | 3.04M | -2.74M |
| Net income | -21.23M | -2.56M | -3.82M | 2.31M | 3.92M |
| Change in cash | 0.72M | -0.04M | 0.03M | -0.03M | 0.05M |
| Begin period cash flow | 0.01M | 0.05M | 0.02M | 0.05M | 0.00M |
| End period cash flow | 0.73M | 0.01M | 0.05M | 0.02M | 0.05M |
| Total cash from operating activities | -4.41M | 3.82M | 1.45M | -2.89M | 3.72M |
| Issuance of capital stock | 5.03M | 0.00M | - | - | - |
| Depreciation | 0.39M | 0.52M | 0.31M | 0.24M | 0.39M |
| Other cashflows from investing activities | -4.11M | - | - | - | - |
| Dividends paid | 0.70M | - | 0.39M | - | -3.95M |
| Change to inventory | -1.28M | 4.12M | - | - | - |
| Change to account receivables | 0.29M | 4.26M | 3.92M | -4.87M | -1.07M |
| Sale purchase of stock | - | 0.00M | -0.39M | 0.00M | - |
| Other cashflows from financing activities | 0.55M | -0.21M | - | - | - |
| Capital expenditures | 0.12M | 0.12M | 0.21M | 0.17M | 1.17M |
| Change in working capital | 1.62M | 5.45M | 4.13M | -5.97M | -0.33M |
| Other non cash items | 7.63M | 5.45M | 0.80M | - | - |
| Free cash flow | -4.53M | 3.70M | 1.24M | -3.06M | 2.55M |
Sector: Basic Materials Industry: Building Materials
|
Stock Name
|
Change
(USD) |
Price
(USD) |
Trailing
PE (x) |
Forward
PE (x) |
Price Sales
TTM (x) |
Price to Book Value (x)
|
Enterprise Value
to Revenue (x) |
Enterprise Value
to EBITDA (x) |
|---|---|---|---|---|---|---|---|---|
| CAPS Capstone Holding Corp. Common Stock |
0.13 6.84% |
2.03 | - | - | 0.09 | 0.38 | 0.74 | 14.17 |
| CRH CRH PLC |
2.12 2.24% |
96.94 | 21.52 | 19.53 | 2.12 | 3.30 | 2.53 | 12.20 |
| HCMLF Holcim Ltd |
-0.05 0.06% |
90.30 | 97.65 | 14.71 | 2.91 | 2.39 | 2.62 | 15.46 |
| HCMLY Lafargeholcim Ltd ADR |
0.28 1.58% |
18.05 | 97.65 | 14.71 | 2.91 | 2.37 | 2.59 | 15.33 |
| MLM Martin Marietta Materials Inc |
10.15 1.96% |
528.30 | 32.95 | 21.05 | 5.38 | 3.08 | 6.25 | 20.05 |
Capstone Holding Corp. engages in the distribution of masonry stone products in the Midwest and Northeast United States. The company offers masonry stone products, such as manufactured and natural stone cladding products, natural stone landscape products, and related goods for residential and commercial construction. The company was formerly known as Capstone Therapeutics Corp. and changed its name to Capstone Holding Corp. in February 2022. Capstone Holding Corp. was incorporated in 1987 and is based in Alsip, Illinois.
5141 W. 122nd Street, Alsip, IL, United States, 60803
708 371 0660
36
| Name | Title | Year Born |
|---|---|---|
| Mr. Michael M. Toporek | CEO, Pres & Chairman | 1966 |
| Mr. Omar Rabbani | CFO, VP & Treasurer | NA |
| Mr. Wardell M. William | Head of Clinical & Regulatory Review Board | 1939 |
| Mr. Matthew E. Lipman | VP, Sec. & Director | 1979 |
| Mr. Michael M. Toporek III | CEO, President & Chairman | 1966 |
| Mr. Edward C. Schultz | VP, CFO & Treasurer | 1985 |
| Mr. Matthew E. Lipman | VP, Secretary & Director | 1979 |
| Mr. Matthew E. Lipman | CEO, Secretary & Director | 1979 |
| Mr. Edward C. Schultz | Chief Financial Officer | 1985 |
| Mr. Kevin Grotke | President & Chief Executive Officer of TotalStone, LLC | NA |
Disclaimer - (*)This information, including any data, is sourced from Unicorn Data Services SAS, trading as EOD Historical Data (“EODHD”) on an ‘as is’ basis, using their API. We cannot guarantee the completeness or validity of the information and data provided on this page, as well as via the API. In some cases, the data may include analyst ratings or recommendations sourced through the EODHD API, which are intended solely for general information purposes.
This information does not consider your personal objectives, financial situation, or needs. Kalkine is not liable for any errors or omissions in the information provided or for any actions taken in reliance on it. You should seek advice from a financial adviser, stockbroker or other professional adviser (including taxation and legal advice) as necessary before acting on this information.